Early hemoglobin decline and survival prognosis in epoetin alfa studies

被引：0
|
作者：
Berlin, J. A.
Bowers, P. J.
Rao, S.
Sun, S.
Liu, K.
Henry, D. H.
机构：
[1] Johnson & Johnson PRD, Titusville, NJ USA
[2] Johnson & Johnson PRD, Raritan, NJ USA
[3] Pennsylvania Oncol Hematol Associates, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9625
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Effective hemoglobin (HB) control with epogen (epoetin alfa) in the real-world clinical setting
    Belozeroff, Vasily
    Smirnakis, Karen
    Johnson, Steven
    Krishnan, Mahesh
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (04) : A30 - A30
  • [22] Epoetin alfa use in patients with ESRD: An analysis of recent US prescribing patterns and hemoglobin outcomes
    Collins, AJ
    Brenner, RM
    Ofman, JJ
    Chi, EM
    Stuccio-White, N
    Krishnan, M
    Solid, C
    Ofsthun, NJ
    Lazarus, JM
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (03) : 481 - 488
  • [23] Strategies for optimizing hemoglobin response in cancer patients: focus on new epoetin alfa dosing regimens
    Sabbatini, P
    EJC SUPPLEMENTS, 2004, 2 (02): : 36 - 40
  • [24] Assessment of hemoglobin responsiveness to epoetin alfa in patients on hemodialysis using a population pharmacokinetic pharmacodynamic model
    Wu, Liviawati
    Mould, Diane R.
    Ruixo, Juan Jose Perez
    Doshi, Sameer
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (10): : 1157 - 1166
  • [25] Effect of Epoetin Alfa Dose Changes on Hemoglobin and Mortality in Hemodialysis Patients with Hemoglobin Levels Persistently below 11 g/dL
    Bradbury, Brian D.
    Danese, Mark D.
    Gleeson, Michelle
    Critchlow, Cathy W.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (03): : 630 - 637
  • [26] Prevention of anemia by early intervention with once weekly epoetin alfa during chemotherapy
    Codrington, H.
    Schouwink, J. H.
    Sleeboom, H. P.
    Kerkhofs, L. G. M.
    Wormhoudt, L. W.
    EJC SUPPLEMENTS, 2007, 5 (04): : 148 - 148
  • [27] Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy
    Schoulwink, J. H.
    Codrington, H.
    Sleeboom, H. P.
    Kerkhofs, L. G. M.
    Wormhoudt, L. W.
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (06) : 819 - 829
  • [28] Dosing intervals and hemoglobin control in patients with chronic kidney disease and anemia treated with epoetin alfa or darbepoetin alfa: A retrospective cohort study
    Nurko, Saul
    Spirko, Rita
    Law, Amy
    Dennis, Vincent W.
    CLINICAL THERAPEUTICS, 2007, 29 (09) : 2010 - 2021
  • [29] Epoetin alfa 40000 U once weekly and intravenous iron supply in solid tumor patients: Early increase of hemoglobin level during chemotherapy
    Lalle, M
    Pistillucci, G
    Antimi, M
    D'Aprile, M
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2005, 24 (02) : 196 - 201
  • [30] Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study
    Leyland-Jones, B
    Semiglazov, V
    Pawlicki, M
    Pienkowski, T
    Tjulandin, S
    Manikhas, G
    Makhson, A
    Roth, A
    Dodwell, D
    Baselga, J
    Biakhov, M
    Valuckas, K
    Voznyi, E
    Liu, XY
    Vercammen, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 5960 - 5972
12345